Can You Buy OpenAI Stock?
Erik James Roberts — Founder & CIO, Infinitus Wealth Management. Purple Heart recipient, Wharton MBA.
Updated October 1, 2026
Can you buy OpenAI stock? Not on a public exchange, not yet. OpenAI has no ticker symbol, and its initial public offering has moved to 2027 at the earliest. What accredited investors can do today is indicate interest in a pre-IPO special purpose vehicle, a pooled fund that holds OpenAI shares, through platforms that package late-stage private-company stock. Infinitus clients who qualify can submit indications of interest in select pre-IPO offerings through our custodian, Altruist. This article explains exactly how that works, who qualifies, what an indication of interest commits you to, and how a position like this fits inside a real portfolio.
Pre-IPO Investing Is Available to Infinitus Clients
Infinitus clients have access to pre-IPO investing in select late-stage private companies. These are businesses that have not yet listed on a public exchange, the stage where much of a company's growth now happens before everyday investors can buy a share. Availability rotates, is limited to accredited investors, and is never guaranteed, and securities regulations limit what we can say publicly about specific offerings, including which companies are available at any given time. If you are an accredited investor, contact us and we will talk through whether a position like this fits your overall portfolio.
The practical side is simple. There is no separate platform, no outside login, and no standalone paperwork firm. Eligible clients subscribe through our custodian, Altruist, with digital signatures, fund the investment from cash in their account, and once the subscription settles the position appears on the same statements as their other holdings.
Can You Buy OpenAI Stock on the Stock Market Today?
No. OpenAI remains a private company. It confidentially submitted a draft S-1 registration statement to the SEC on June 8, 2026, which is the first formal step toward a listing, but CEO Sam Altman has since said on the record that the company will not list in 2026. Reports now point to 2027 at the earliest.
That means every "OpenAI stock" search result promising a ticker or a share price for a brokerage app is either describing a private secondary transaction or selling something else entirely. The public market route is closed until the S-1 goes effective and the shares price. When that happens, the listing is expected to be one of the largest technology IPOs in history, and demand at the opening bell is likely to be intense.
For most investors, the practical answer is to wait for the IPO and buy shares on the exchange like any other stock. For accredited investors with the capacity and the patience for an illiquid holding, there is an earlier door.
Where OpenAI's Valuation Stands Right Now
Before asking can you buy OpenAI stock at a fair price, it helps to see where the valuation stands, because every pre-IPO entry is priced off these numbers.
OpenAI closed a $122 billion funding round on March 31, 2026 at an $852 billion post-money valuation, the largest private round ever completed. An employee tender offer in August 2026 priced flat at that same figure. On September 29, Bloomberg reported that OpenAI is in early talks to raise at least $30 billion more at a valuation of roughly $1.4 trillion, a round described as a bridge to the IPO. That figure is a report, not a closed transaction, and it is worth keeping the two categories separate.
On the revenue side, reporting puts OpenAI's annualized run-rate at roughly $40 billion as of August 2026, up sharply since July as the company refocused on areas like coding. For context, the valuation path from the last few rounds looks like this: $157 billion in October 2024, $300 billion in March 2025, $500 billion in the October 2025 share sale, $852 billion in March 2026, and a reported $1.4 trillion target today.
Past valuation increases are not an indication of future valuation, and private-round pricing is set by a small number of institutional buyers rather than a daily public market.
Can You Buy OpenAI Stock Before the IPO as an Accredited Investor?
Can you buy OpenAI stock as a private investor? Yes, if you are an accredited investor, and nearly always through a structure called a special purpose vehicle rather than by holding shares directly.
A special purpose vehicle, or SPV, is a limited liability company or limited partnership formed for one purpose: to hold a block of shares in a single private company. Investors buy membership units in the SPV, and the SPV holds the OpenAI stock. You own a slice of the vehicle, not a line item on OpenAI's cap table. The sponsor that forms and manages the SPV sources the shares, handles the paperwork with the company, and charges fees that are disclosed in the offering documents.
Here is what changed in September 2026 that makes this relevant to Infinitus clients. Altruist, the custodian that holds Infinitus client accounts, expanded its alternatives marketplace to include pre-IPO SPVs sourced and sponsored by its partner, Monark Capital Management LLC. Monark is a private-markets firm that packages late-stage private-company shares into SPVs for advisor platforms. The subscription workflow, including digital signatures and accreditation attestation, runs inside Altruist, and the position shows up alongside a client's stocks and bonds in the same account view.
Offerings on that marketplace rotate based on what the sponsor sources, and OpenAI is among the late-stage companies that appear on pre-IPO platforms of this kind. Infinitus clients who meet the accredited investor standard can submit an indication of interest in select pre-IPO offerings through us. Availability is limited and never guaranteed, there may be no live offering at a given moment, and a prospective offering may never open.
Two features of the SPV route deserve plain language. First, the minimum investment on these offerings is typically $50,000 or more, which is a meaningful position for most households and should be sized accordingly. Second, the units are illiquid. There is no exchange to sell on, transfer restrictions apply, and your capital is committed until a liquidity event such as the IPO and any post-IPO lockup, an acquisition, or a sponsor-arranged secondary sale. Plan to hold for years, not months.
Who Qualifies as an Accredited Investor?
The SEC defines accredited investor status in Rule 501 of Regulation D, and as of October 2026 the individual tests are unchanged. You qualify through any one of three paths:
Income: $200,000 of individual income, or $300,000 jointly with a spouse or spousal equivalent, in each of the last two years with a reasonable expectation of the same this year.
Net worth: more than $1 million, individually or jointly, excluding the value of your primary residence.
Professional credential: an active Series 7, 65, or 82 license, regardless of income or net worth.
Certain entities also qualify, including trusts and companies with more than $5 million in assets and entities owned entirely by accredited investors. The SEC's regulatory agenda lists possible amendments to the definition, but no formal proposal has been issued as of this writing.
On the Altruist platform, both the advisor and the client attest to the client's accredited status before a subscription can be completed. This is not a box to check casually. The attestation is a representation made in connection with a securities offering, and we review it with every client.
What an Indication of Interest Actually Means
An indication of interest, or IOI, is a non-binding signal that you want to participate in an offering if and when it opens. It is not a purchase, it does not move money, and it does not guarantee you an allocation. What it does is place you in line. When the sponsor finalizes an offering, investors who submitted an IOI are notified first and given the opportunity to complete a subscription, which is the binding step.
For Infinitus clients, the sequence looks like this. We confirm accredited status and discuss whether the position makes sense for your portfolio. If it does, we submit the IOI through Altruist on your behalf. If the offering goes live, we review the final terms with you, including the SPV's price per unit, the sponsor's fees, and the transfer restrictions, before any subscription is signed. Only then does capital move.
The gap between an IOI and a completed subscription is where the real decision gets made, and we treat it that way.
Fitting a Pre-IPO Position Into a Real Portfolio
Infinitus builds client portfolios from individual stocks and bonds, selected and managed one position at a time. A pre-IPO SPV sits outside that core as a satellite position with its own rules.
Three principles govern how we size one. The first is concentration. A single private company, however compelling, is one holding with binary outcomes, and we size it so that a full write-down would not change a client's financial plan. The second is liquidity. Capital committed to an SPV is unavailable for years, so it must come from assets a client will not need for spending, taxes, or rebalancing across that horizon. The third is cost. SPV sponsors charge management fees and often a carried interest on gains, and those costs sit on top of the entry valuation, which means the position needs to clear a higher bar than a public stock to earn the same net return.
For clients who want exposure to private companies as a theme rather than a single name, our Private Companies strategy approaches the category with curated deal flow and the same research discipline we apply to public securities. A single-name SPV like OpenAI can complement that, but it is not a substitute for a diversified portfolio of liquid, individually selected securities.
Other Ways to Get OpenAI Exposure Without Buying OpenAI Stock
Investors who are not accredited, or who prefer liquidity, can hold public companies with economic ties to OpenAI. Microsoft holds a large minority stake in OpenAI's for-profit entity following the company's 2025 restructuring, and OpenAI's compute commitments run through Microsoft's cloud business. SoftBank led OpenAI's recent rounds and trades publicly in Tokyo with an American depositary receipt available to U.S. investors. Nvidia supplies the chips OpenAI's infrastructure depends on and has announced its own investment commitments.
Each of these is a large, diversified business where OpenAI is one input among many, so the exposure is diluted. None of this is a recommendation to buy or sell any security. It is simply the map of where OpenAI's economics already touch the public market.
Frequently Asked Questions
Is OpenAI publicly traded?
No. OpenAI is a private company. It confidentially filed a draft S-1 with the SEC in June 2026, and its IPO is now expected in 2027 at the earliest.
What is OpenAI's stock symbol?
OpenAI has no stock symbol. A ticker is typically disclosed when a company publicly files its S-1, which OpenAI has not yet done.
How much does it cost to buy OpenAI stock before the IPO?
Pre-IPO SPV minimums are typically $50,000 or more. Pricing is set per offering by the sponsor and disclosed in the offering documents, along with the sponsor's fees.
Can Infinitus clients invest in pre-IPO companies like OpenAI?
Infinitus clients who meet the SEC's accredited investor definition can submit indications of interest in select pre-IPO SPV offerings through our custodian, Altruist. Which companies are available at any given time is set by the sponsor, and availability is limited and not guaranteed.
What is the difference between an IOI and a subscription?
An indication of interest is non-binding and moves no money. A subscription is the binding agreement to purchase units in the SPV, signed only after an offering goes live and final terms are disclosed.
When will OpenAI IPO?
As of October 2026, 2027 is the earliest reported timeline. OpenAI has not announced a date, and the timing depends on the SEC review process, market conditions, and the company's own decisions.
Ready to talk about whether a pre-IPO position fits your portfolio? Infinitus builds custom portfolios of individual stocks and bonds for accredited and non-accredited investors alike, and for qualifying clients we can facilitate indications of interest in select pre-IPO offerings through Altruist.
Disclosure. Infinitus Wealth Management is a fee-only, independent registered investment adviser. This article is for educational purposes only and does not constitute investment, legal, or tax advice, nor an offer to sell or a solicitation of an offer to buy any security. Any pre-IPO offering is made only through the sponsor's offering documents, which contain complete information on risks, fees, and terms, and only to investors who meet applicable eligibility requirements, including accredited investor status. Pre-IPO investments through special purpose vehicles are speculative, illiquid, subject to transfer restrictions, and may result in the loss of the entire investment. Availability of any offering is limited and not guaranteed, an indication of interest is non-binding and does not guarantee an allocation, and a prospective offering may never open. The pre-IPO opportunities available through Altruist Financial LLC, member FINRA/SIPC, are sourced and sponsored by Monark Capital Management LLC; Altruist facilitates subscription and custody and does not sponsor or manage the underlying offerings. Infinitus is not affiliated with OpenAI, Monark, or Altruist beyond its custodial relationship. Valuation and financial figures cited are drawn from public reporting as of October 1, 2026, have not been independently verified, and may change. Past valuation increases are not indicative of future results. Investing involves risk, including possible loss of principal. Consult your financial, legal, and tax professionals before making any investment decision.
